Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Myrexis Inc    MYRX

MYREXIS INC (MYRX)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 01/12 09:59:34 pm
0.04776 USD   +27.36%
 SummaryQuotesChartsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
01/08/2018 01/09/2018 01/10/2018 01/11/2018 01/12/2018 Date
0.04(c) 0(c) 0.04(c) 0.0375(c) 0.04776(c) Last
72 210 25 62 600 86 337 110 Volume
-30.92% -100.00% -6.25% +27.36% Change
More quotes
Company
Myrexis, Inc. is in the process of evaluating strategic alternatives, including focusing on identifying, evaluating and making financial investments in life sciences assets.The company was founded in January 2009 and is headquartered in New York, NY. 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on MYREXIS INC

- No features available -

More news
Sector news : Biopharmaceuticals
01/15 Drugmaker Dermapharm gears up for likely first German IPO of 2018
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
01/12 ASTRAZENECA : Receives FDA Approval for Breast Cancer Treatment
01/12 WPP Buys London-based Mash Strategy
More sector news : Biopharmaceuticals
Chart MYREXIS INC
Duration : Period :
Myrexis Inc Technical Analysis Chart | MYRX | US62856H1077 | 4-Traders
Managers
NameTitle
Jonathan M. Couchman Chairman, President, Chief Executive Officer & CFO
Steven D. Scheiwe Director
Michael Cooper Pearce Director
Gary S. Mather Vice President-Toxicology
Sector and Competitors
1st jan.Capitalization (M$)
MYREXIS INC34.54%2
BIOGEN5.46%71 046
CSL LIMITED0.38%51 171
ALEXION PHARMACEUTICALS2.61%27 415
GRIFOLS SA8.37%20 127
BIOMARIN PHARMACEUTICAL1.18%15 845